Nordea Investment Management AB Increases Stake in HCA Healthcare, Inc. $HCA

Nordea Investment Management AB raised its position in HCA Healthcare, Inc. (NYSE:HCA) by 5.2% in the third quarter, Holdings Channel reports. The fund owned 975,741 shares of the company’s stock after buying an additional 47,960 shares during the period. Nordea Investment Management AB’s holdings in HCA Healthcare were worth $415,656,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Ameriflex Group Inc. purchased a new stake in HCA Healthcare during the 2nd quarter worth about $27,000. Chung Wu Investment Group LLC purchased a new stake in HCA Healthcare during the second quarter worth approximately $27,000. Clearstead Trust LLC increased its stake in HCA Healthcare by 311.8% in the second quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock valued at $27,000 after purchasing an additional 53 shares during the last quarter. Harbor Capital Advisors Inc. boosted its holdings in shares of HCA Healthcare by 82.9% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock valued at $32,000 after buying an additional 34 shares in the last quarter. Finally, Twin Peaks Wealth Advisors LLC acquired a new stake in HCA Healthcare during the 2nd quarter worth $40,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insiders Place Their Bets

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of the business’s stock in a transaction on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total value of $1,843,990.68. Following the transaction, the executive vice president owned 3,487 shares in the company, valued at $1,652,105.73. The trade was a 52.74% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 1.30% of the stock is currently owned by corporate insiders.

HCA Healthcare Trading Up 0.5%

NYSE HCA opened at $474.23 on Tuesday. The stock has a market capitalization of $108.21 billion, a price-to-earnings ratio of 18.33, a PEG ratio of 1.30 and a beta of 1.36. HCA Healthcare, Inc. has a 12-month low of $295.00 and a 12-month high of $520.00. The business’s 50 day moving average is $480.14 and its two-hundred day moving average is $428.44.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, beating the consensus estimate of $5.64 by $1.32. The firm had revenue of $19.16 billion during the quarter, compared to the consensus estimate of $18.55 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.HCA Healthcare’s quarterly revenue was up 9.6% on a year-over-year basis. During the same period last year, the business posted $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Equities analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, December 29th. Investors of record on Monday, December 15th were given a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend was Monday, December 15th. HCA Healthcare’s dividend payout ratio is 11.13%.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the company. Wells Fargo & Company lifted their target price on HCA Healthcare from $431.00 to $452.00 and gave the stock an “equal weight” rating in a research report on Wednesday, January 7th. Morgan Stanley downgraded HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $425.00 price objective for the company. in a report on Monday, December 15th. Cantor Fitzgerald reiterated an “overweight” rating on shares of HCA Healthcare in a research report on Monday, October 27th. Raymond James Financial set a $525.00 price objective on shares of HCA Healthcare in a research note on Monday, October 27th. Finally, Weiss Ratings restated a “buy (b)” rating on shares of HCA Healthcare in a research report on Monday, December 29th. Fourteen analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and an average price target of $485.95.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.